Bonfrer JM - Search Results

1

Highly elevated serum CA 125 levels in a patient with cardiac failure.

Hopman EH, Helmerhorst TJ, Bonfrer JM, Ten Bokkel Huinink WW. Hopman EH, et al. Among authors: bonfrer jm. Eur J Obstet Gynecol Reprod Biol. 1993 Jan;48(1):71-3. doi: 10.1016/0028-2243(93)90056-i. Eur J Obstet Gynecol Reprod Biol. 1993. PMID: 8449265

2

Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer.

Bonfrer JM, Gaarenstroom KN, Kenter GG, Korse CM, Hart AA, Gallee MP, Helmerhorst TJ, Kenemans P. Bonfrer JM, et al. Gynecol Oncol. 1994 Dec;55(3 Pt 1):371-5. doi: 10.1006/gyno.1994.1309. Gynecol Oncol. 1994. PMID: 7530676

3

CA 125: a valid marker in ovarian carcinoma patients treated with paclitaxel?

Davelaar EM, Bonfrer JM, Verstraeten RA, ten Bokkel Huinink WW, Kenemans P. Davelaar EM, et al. Among authors: bonfrer jm. Cancer. 1996 Jul 1;78(1):118-27. doi: 10.1002/(SICI)1097-0142(19960701)78:1<118::AID-CNCR17>3.0.CO;2-2. Cancer. 1996. PMID: 8646707

4

Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.

Gaarenstroom KN, Bonfrer JM, Kenter GG, Korse CM, Hart AA, Trimbos JB, Helmerhorst TJ. Gaarenstroom KN, et al. Among authors: bonfrer jm. Cancer. 1995 Sep 1;76(5):807-13. doi: 10.1002/1097-0142(19950901)76:5<807::aid-cncr2820760515>3.0.co;2-m. Cancer. 1995. PMID: 8625184

5

Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.

Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Gallee MP, Hart AA, Müller M, Trimbos JB, Helmerhorst TJ. Gaarenstroom KN, et al. Among authors: bonfrer jm. Cancer. 1994 Oct 15;74(8):2307-13. doi: 10.1002/1097-0142(19941015)74:8<2307::aid-cncr2820740815>3.0.co;2-x. Cancer. 1994. PMID: 7922982

6

Metastatic ovarian or colonic cancer: a clinical challenge.

Taal BG, Hageman PC, Delemarre JF, Bonfrèr JM, den Hartog Jager FC. Taal BG, et al. Among authors: bonfrer jm. Eur J Cancer. 1992;28(2-3):394-9. doi: 10.1016/s0959-8049(05)80061-9. Eur J Cancer. 1992. PMID: 1591052

7

Effect of paclitaxel (Taxol) on CA 125 expression and release by ovarian cancer cell lines.

Bonfrer JM, Linders TC, Hageman PC, Hilkens JG, Korse CM, Molthoff CF. Bonfrer JM, et al. Tumour Biol. 1997;18(4):232-40. doi: 10.1159/000218036. Tumour Biol. 1997. PMID: 9218008

8

Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.

Mulders TM, Bruning PF, Bonfrer JM. Mulders TM, et al. Among authors: bonfrer jm. Eur J Surg Oncol. 1990 Feb;16(1):37-41. Eur J Surg Oncol. 1990. PMID: 1689677 Review.

9

Serum S-100 has prognostic significance in malignant melanoma.

Bonfrer JM, Korse CM, Israels SP. Bonfrer JM, et al. Anticancer Res. 1997 Jul-Aug;17(4B):2975-7. Anticancer Res. 1997. PMID: 9329579

10

TPA and CA 15.3 measurements for breast cancer monitoring in a routine setting.

Bonfrer JM, Korse CM. Bonfrer JM, et al. Int J Biol Markers. 1999 Jan-Mar;14(1):40-4. doi: 10.1177/172460089901400108. Int J Biol Markers. 1999. PMID: 10367249 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page